83 related articles for article (PubMed ID: 10021301)
21. Effect of retinoic acid on HPV titration and colposcopic changes in Korean patients with dysplasia of the uterine cervix.
Ahn WS; Lee JM; Namkoong SE; Lee HY; Kim SJ
J Cell Biochem Suppl; 1997; 28-29():133-9. PubMed ID: 9589358
[TBL] [Abstract][Full Text] [Related]
22. Polymerase chain reaction and direct DNA tests in detection of human papillomavirus (HPV) DNA in cytologically normal and abnormal cervical smears. Scandinavian Multicenter Study Group.
Acta Obstet Gynecol Scand; 1992 Feb; 71(2):98-103. PubMed ID: 1316053
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the validity of human papillomavirus detection in paraffin-embedded cervical samples by the DNA hybridization in situ.
Kolár Z; Kotrsová L; Krcmár M
Acta Univ Palacki Olomuc Fac Med; 1993; 136():19-21. PubMed ID: 7887193
[TBL] [Abstract][Full Text] [Related]
24. Detection of human papillomavirus DNA by in situ hybridization and polymerase chain reaction in human papillomavirus equivocal and dysplastic cervical biopsies.
Shroyer KR; Lovelace GS; Abarca ML; Fennell RH; Corkill ME; Woodard WD; Davilla GH
Hum Pathol; 1993 Sep; 24(9):1012-6. PubMed ID: 8253456
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus infection and risk of progression of epithelial abnormalities of the cervix.
Woodman CB; Rollason T; Ellis J; Tierney R; Wilson S; Young L
Br J Cancer; 1996 Feb; 73(4):553-6. PubMed ID: 8595174
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus: detection of viral DNA sequences and evidence for molecular heterogeneity in metaplasias and dysplasias of the uterine cervix.
Lancaster WD; Kurman RJ; Sanz LE; Perry S; Jenson AB
Intervirology; 1983; 20(4):202-12. PubMed ID: 6317605
[TBL] [Abstract][Full Text] [Related]
27. Subclinical cervicovaginal human papillomavirus infections associated with cervical condylomata and dysplasia. Treatment outcomes.
Husseinzadeh N; Guoth JG; Jayawardena DS
J Reprod Med; 1994 Oct; 39(10):777-80. PubMed ID: 7837123
[TBL] [Abstract][Full Text] [Related]
28. Rare association of human herpesvirus 6 DNA with human papillomavirus DNA in cervical smears of women with normal and abnormal cytologies.
Romano N; Romano FM; Viviano E; Vitale F; Villafrate MR; Perna AM; Bonura F; Guttadauro R
J Clin Microbiol; 1996 Jun; 34(6):1589-91. PubMed ID: 8735129
[TBL] [Abstract][Full Text] [Related]
29. HPV detection in cytological cases with condylomatous or dysplastic changes: a study with PCR and in situ hybridization on cytological material.
Skyldberg B; Hagmar B; Johansson B; Kalantari M; Moberger B; Walaas L; Wärleby B
Diagn Cytopathol; 1995 Jul; 13(1):8-14. PubMed ID: 7587882
[TBL] [Abstract][Full Text] [Related]
30. Folate, vitamin B12, and homocysteine status. findings of no relation between human papillomavirus persistence and cervical dysplasia.
Sedjo RL; Fowler BM; Schneider A; Henning SM; Hatch K; Giuliano AR
Nutrition; 2003 Jun; 19(6):497-502. PubMed ID: 12781848
[TBL] [Abstract][Full Text] [Related]
31. Biochemical fingerprints of human papillomavirus infection and cervical dysplasia using cervical fluids: Spectral pattern investigation.
Kim YH; Chang B; Choi JH; Park HK; Choi S
Microsc Res Tech; 2016 Oct; 79(10):966-972. PubMed ID: 27435509
[TBL] [Abstract][Full Text] [Related]
32. ["Nested" PCR for human papillomavirus detection and typing in samples from cervical lesions of gynecological patients].
Kurillová L; Simko J; Holomán K; Suska P; Rusnák I
Ceska Gynekol; 2004 Jul; 69(4):287-92. PubMed ID: 15369248
[TBL] [Abstract][Full Text] [Related]
33. The management of minor degrees of cervical dysplasia associated with the human papilloma virus.
Carmichael JA
Yale J Biol Med; 1991; 64(6):591-7. PubMed ID: 1667239
[TBL] [Abstract][Full Text] [Related]
34. HPV DNA positivity and natural killer cell activity in the clinical outcome of mild cervical dysplasia: integration between virus and immune system.
Garzetti GG; Ciavattini A; Goteri G; De Nictolis M; Menso S; Muzzioli M; Fabris N
Gynecol Obstet Invest; 1995; 39(2):130-5. PubMed ID: 7737583
[TBL] [Abstract][Full Text] [Related]
35. Detection of human papillomavirus type 52b in cervical dysplastic tissue.
Yaegashi N; Yajima H; Konno R; Shikano K; Sato S; Yajima A
Tohoku J Exp Med; 1989 Nov; 159(3):215-9. PubMed ID: 2560268
[TBL] [Abstract][Full Text] [Related]
36. Non-detection of human papillomavirus DNA in cervical dysplasia and disease progression.
Iwasaka T; Matsuo N; Yokoyama M; Sugimori H
Lancet; 1996 Aug; 348(9023):333-4. PubMed ID: 8709702
[No Abstract] [Full Text] [Related]
37. Multimodal entity coreference for cervical dysplasia diagnosis.
Song D; Kim E; Huang X; Patruno J; Munoz-Avila H; Heflin J; Long LR; Antani S
IEEE Trans Med Imaging; 2015 Jan; 34(1):229-45. PubMed ID: 25167547
[TBL] [Abstract][Full Text] [Related]
38. Effect of cryotherapy and povidone-iodine preparation on eradication of DNA corresponding to highly oncogenic HPV in women with lesions in the uterine cervix.
Markowska J
Eur J Gynaecol Oncol; 2012; 33(3):249-51. PubMed ID: 22873091
[TBL] [Abstract][Full Text] [Related]
39. [DNA in koilocytotic dysplasia of the cervix uteri, cytophotometric studies].
Christov K; Karageosov I; Makaveeva V; Kristeva K
Zentralbl Gynakol; 1987; 109(16):1033-7. PubMed ID: 3673324
[TBL] [Abstract][Full Text] [Related]
40. [Uterine cervix dysplasias. New therapeutic strategy based on virological data].
Parent B; Huynh B
J Gynecol Obstet Biol Reprod (Paris); 1986; 15(7):941-7. PubMed ID: 3027158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
